Supine hypertension in Parkinson’s disease and multiple system atrophy

Clinical Autonomic Research

Volumn 26, Issue 2, 2016, Pages 97-105

  Fanciulli, Alessandra ^a,b   Göbel, Georg ^a   Ndayisaba, Jean Pierre ^a   Granata, Roberta ^a   Duerr, Susanne ^a   Strano, Stefano ^c   Colosimo, Carlo ^d   Poewe, Werner ^a   Pontieri, Francesco E ^b,e   Wenning, Gregor K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Azienda Ospedaliero Universitaria di Terni   (Italy)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Multiple system atrophy; Orthostatic hypotension; Parkinson s disease; Parkinson s disease with dementia; Supine hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR SYSTEM EXAMINATION; COHORT ANALYSIS; COMORBIDITY; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC BLOOD PRESSURE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; RETROSPECTIVE STUDY; SHY DRAGER SYNDROME; SUPINE HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TILT TEST EXAMINATION; AUTONOMIC NEUROPATHY; CARDIOVASCULAR SYSTEM; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; SUPINE POSITION; TILT TABLE TEST;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR SYSTEM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SUPINE POSITION; TILT-TABLE TEST;

EID: 84955308929     PISSN: 09599851     EISSN: 16191560     Source Type: Journal    
DOI: 10.1007/s10286-015-0336-4     Document Type: Article

References (41)

1. Freeman R et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72
2. Schroeder C, Jordan J, Kaufmann H (2013) Management of neurogenic orthostatic hypotension in patients with autonomic failure. Drugs 73(12):1267–1279
3. Velseboer DC et al (2011) Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17(10):724–729
4. Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249–263
5. Wenning GK et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274
6. Low PA et al (2015) Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14(7):710–719
7. Fanciulli A et al (2014) Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol
8. Plaschke M et al (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16(10):1433–1441
9. Jordan J et al (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10(1):35–42
10. Fanciulli A et al (2013) The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies. Eur J Neurol 20(2):231–235
11. Kim JS et al (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331
12. Pilleri M et al (2013) Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol 260(1):253–259
13. Oh YS, Kim JS, Lee KS (2013) Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease. J Mov Disord 6(2):23–27
14. Lim TS et al (2009) White matter hyperintensities in patients with multiple system atrophy. J Neurol 256(10):1663–1670
15. Jones JD et al (2014) Influence of hypertension on neurocognitive domains in nondemented Parkinson’s disease patients. Parkinsons Dis 2014:507529
16. Anang JB et al (2014) Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83(14):1253–1260
17. Biaggioni I, Robertson RM (2002) Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin 20(2):291–301 (vii)
18. Shannon J et al (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062–1067
19. Pavy-Le Traon A et al (2015) New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry (e-pub ahead of print)
20. Schutzman J et al (1994) Head-up tilt and hemodynamic changes during orthostatic hypotension in patients with supine hypertension. J Am Coll Cardiol 24(2):454–461
21. Chobanian AV et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252
22. Hughes AJ et al (2001) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. 1992. Neurology. 57(10 Suppl 3):S34–S38
23. Emre M et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707
24. Gilman S et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676
25. Tomlinson CL et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653
26. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57(1):289–300
27. Rose KM et al (2000) Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis risk in communities study. Am J Hypertens 13(6 Pt 1):571–578
28. Fedorowski A et al (2010) Orthostatic hypotension predicts incidence of heart failure: the Malmo preventive project. Am J Hypertens 23(11):1209–1215
29. Goldstein DS et al (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136–142
30. Benarroch EE, Schmeichel AM, Parisi JE (2003) Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy. Neurology 60(1):115–117
31. Benarroch EE et al (2006) Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 66(3):378–383
32. Benarroch EE (2003) Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol 23(4–5):519–526
33. Davies B et al (1982) Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. J Clin Invest 69(4):779–784
34. Hohler AD et al (2012) Differences in motor and cognitive function in patients with Parkinson’s disease with and without orthostatic hypotension. Int J Neurosci 122(5):233–236
35. Allcock LM et al (2006) Orthostatic hypotension in Parkinson’s disease: association with cognitive decline? Int J Geriatr Psychiatry 21(8):778–783
36. Peralta C et al (2007) Orthostatic hypotension and attention in Parkinson’s disease with and without dementia. J Neural Transm 114(5):585–588
37. Wenning GK et al (2012) Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study. Cerebellum 11(1):223–226
38. Vanacore N et al (2000) Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology 54(1):114–119
39. Allam MF et al (2004) Smoking and Parkinson’s disease: systematic review of prospective studies. Mov Disord 19(6):614–621
40. Kollensperger M et al (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25(15):2604–2612
41. Gilman S et al (2005) The North American multiple system atrophy study group. J Neural Transm 112(12):1687–1694